We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.23B
AUM Growth
+$298M
(+4.3%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
2.07%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
1,100
New
151
Increased
415
Reduced
333
Closed
164
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.6M |
| 2 |
Autodesk
ADSK
|
+$38.8M |
| 3 |
Intuit
INTU
|
+$37.1M |
| 4 |
Ecolab
ECL
|
+$35.6M |
| 5 |
Coca-Cola
KO
|
+$35.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$51.9M |
| 2 |
EOG Resources
EOG
|
+$33.8M |
| 3 |
DATA
Tableau Software, Inc.
DATA
|
+$32M |
| 4 |
Microsoft
MSFT
|
+$29.8M |
| 5 |
Ford
F
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 17.68% |
| 3 | Consumer Discretionary | 13.74% |
| 4 | Industrials | 11.53% |
| 5 | Healthcare | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Reinsurance Group of America
RGA
$15.7B
| $24.1M | 0.33% |
154,554
+18,051
| +13% | +$2.7M |
|
77
Nike
NKE
$61.9B
| $23.1M | 0.32% |
275,310
-5,870
| -2% | -$494K |
|
78
Arrow Electronics
ARW
$10.9B
| $23.1M | 0.32% |
323,863
-3,310
| -1% | -$244K |
|
79
Centene
CNC
$31.3B
| $22.5M | 0.31% |
429,304
-136,060
| -24% | -$7.35M |
|
|
MNDT
80
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $22.4M | 0.31% |
1,510,010
+520,487
| +53% | +$7.98M |
|
81
ManpowerGroup
MAN
$2.39B
| $22.3M | 0.31% |
230,814
-14,370
| -6% | -$1.31M |
|
82
NRG Energy
NRG
$29.8B
| $22.3M | 0.31% |
633,720
+41,110
| +7% | +$1.55M |
|
83
Allison Transmission
ALSN
$10.1B
| $21.8M | 0.3% |
470,777
-50,350
| -10% | -$2.28M |
|
84
Popular Inc
BPOP
$11B
| $21.6M | 0.3% |
398,993
-29,940
| -7% | -$1.64M |
|
85
Jazz Pharmaceuticals
JAZZ
$15.9B
| $21.6M | 0.3% |
151,344
+32,040
| +27% | +$4.31M |
|
|
ARCH
86
DELISTED
Arch Resources, Inc.
ARCH
| $21.5M | 0.3% |
228,395
+19,780
| +9% | +$1.81M |
|
87
F5
FFIV
$22.1B
| $21.4M | 0.3% |
147,180
+35,488
| +32% | +$5.31M |
|
88
Archer Daniels Midland
ADM
$41.4B
| $21.4M | 0.3% |
524,192
-360,210
| -41% | -$14.9M |
|
89
Camden Property Trust
CPT
$11.3B
| $21M | 0.29% |
200,824
+7,670
| +4% | +$787K |
|
90
HubSpot
HUBS
$10.5B
| $20.9M | 0.29% |
122,330
+6,403
| +6% | +$1.12M |
|
91
Intercontinental Exchange
ICE
$82.4B
| $20.3M | 0.28% |
235,970
+19,270
| +9% | +$1.57M |
|
|
TWTR
92
DELISTED
Twitter, Inc.
TWTR
| $19.9M | 0.28% |
571,574
-197,775
| -26% | -$7.26M |
|
93
Fluor
FLR
$7.29B
| $19.8M | 0.27% |
586,647
-80,786
| -12% | -$2.71M |
|
|
ETFC
94
DELISTED
E*Trade Financial Corporation
ETFC
| $19.7M | 0.27% |
441,490
-108,701
| -20% | -$5.19M |
|
95
Ashland
ASH
$3.04B
| $19.5M | 0.27% |
244,273
+11,860
| +5% | +$916K |
|
96
NewMarket
NEU
$7.17B
| $19.5M | 0.27% |
+48,682
| New | +$20.1M |
|
97
Synchrony
SYF
$23.7B
| $19.4M | 0.27% |
560,870
+166,790
| +42% | +$5.65M |
|
98
Western Digital
WDC
$179B
| $19.3M | 0.27% |
537,334
+68,280
| +15% | +$2.34M |
|
99
Bank of America
BAC
$435B
| $19.1M | 0.26% |
658,330
+507,520
| +337% | +$14.6M |
|
|
SCHW
100
Charles Schwab
SCHW
$177B
| $18.9M | 0.26% |
470,813
+404,013
| +605% | +$17.6M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2019 Portfolio in Review
As of Q2 2019, Jacobs Levy Equity Management held 1,100 positions worth $7.23B, up 4.3% from $6.93B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jacobs Levy Equity Management's Q2 2019 filing shows 151 new, 415 increased, 333 reduced and 164 closed positions. Its largest new stake was Biogen: 175,817 shares worth $41.1M. The largest sale was Allergan plc, an estimated $51.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2019 buy was Biogen: 175,817 shares worth $41.1M.
- Jacobs Levy Equity Management added most to Ecolab in Q2 2019, an estimated $35.6M increase.
- Jacobs Levy Equity Management's biggest Q2 2019 reduction was EOG Resources, cutting an estimated $33.8M.
- Jacobs Levy Equity Management fully exited Allergan plc in Q2 2019, selling an estimated $51.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 15% of its $7.23B portfolio in Q2 2019.
- Jacobs Levy Equity Management opened 151 new positions and closed 164 in Q2 2019.
- Jacobs Levy Equity Management's portfolio value rose 4.3% quarter-over-quarter to $7.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.